Exelixis Inc. (EXEL) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 8:55 PM

Exelixis Inc. (EXEL) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on EXEL
Apple, Tesla hit intraday records; Possible breach at Home Depot 2:15 p.m. Sept. 2, 2014 - Angela Johnson
Exelixis shares plunge 55% after disappointing trial results 8:40 a.m. Sept. 2, 2014 - Tomi Kilgore
Biotechs still sliding, but Wall Street says don't hit panic button just yet 1:43 p.m. March 26, 2014 - Russ Britt
HMA’s pre-emptive strike against ‘60 Minutes’ 4:44 p.m. Nov. 30, 2012 - Russ Britt
Chipotle vs. Taco Bell: testing Einhorn's thesis 5:37 a.m. Oct. 4, 2012 - The Trading Deck
Exelixis prices stock offering at 0.7% discount 11:21 a.m. Aug. 9, 2012 - MarketWatch.com
Exelixis slides 12% on stock, debt offering 2:39 p.m. Aug. 6, 2012 - Val Brickates Kennedy
FDA to speed Exelixis thyroid-cancer-drug review 5:35 a.m. July 30, 2012 - MarketWatch.com
Stocks to watch Thursday: GM, Agilent, NetApp 6:51 a.m. Feb. 16, 2012 - MarketWatch
Exelixis licenses cancer-drug R&D to Merck & Co. 7:26 a.m. Dec. 21, 2011 - MarketWatch.com
Loathe that investment theme? Perfect! 12:03 p.m. Nov. 8, 2011 - The Trading Deck
Exelixis plunges on drug study woes 11:05 a.m. Nov. 1, 2011 - Val Brickates Kennedy
Stocks to watch Tuesday: Exelixis, DirecTV, Leap 5:46 a.m. Nov. 1, 2011 - MarketWatch
Exelixis slides, Allstate up in after-hours trade 5:48 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis shares fall without FDA study commentary 5:05 p.m. Oct. 31, 2011 - Wallace Witkowski
Exelixis shares resume trading, drop 35% 4:44 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis rallies 21% on drug study 10:46 a.m. Oct. 24, 2011 - Val Brickates Kennedy
Icahn reports new stakes in Vector Group, El Paso 6:52 p.m. Aug. 15, 2011 - MarketWatch.com
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:50 p.m. June 6, 2011 - Kate Gibson

Other News on EXEL
Exelixis: Why This Company Could Become The Next Dendreon 12:54 p.m. Nov. 18, 2014 - Seeking Alpha
Update: Exelixis Announces Very Positive Phase 1 Trial Data 1:28 a.m. Nov. 18, 2014 - Seeking Alpha
Biotech Weekly: Here Come The Institutional Holdings Updates 8:31 a.m. Nov. 17, 2014 - Seeking Alpha
Update: Exelixis Reports Q3 Earnings - Impact To My Thesis 4:42 a.m. Nov. 7, 2014 - Seeking Alpha
Exelixis completes enrollment in cabozantinib Phase 3 7:31 a.m. Nov. 6, 2014 - Seeking Alpha
Exelixis' (EXEL) CEO Mike Morrissey on Q3 2014 Results - Earnings Call Transcript 10:42 p.m. Nov. 4, 2014 - Seeking Alpha
Exelixis (EXEL) Q3 2014 Results - Earnings Call Webcast 4:55 p.m. Nov. 4, 2014 - Seeking Alpha
10-Q: EXELIXIS, INC. 4:05 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Tuesday's close 5:35 p.m. Nov. 3, 2014 - Seeking Alpha
Will Exelixis (EXEL) Disappoint This Earnings Season? - Analyst Blog 2:35 p.m. Nov. 3, 2014 - Zacks.com
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 1:53 p.m. Oct. 3, 2014 - Seeking Alpha
Roche Presents Data on Cancer Immunotherapy Candidate - Analyst Blog 9:50 a.m. Oct. 3, 2014 - Zacks.com
Exelixis (EXEL) Is in Oversold Territory: What's Next? - Tale of the Tape 9:41 a.m. Oct. 3, 2014 - Zacks.com
Update: Exelixis Announces Very Positive Results From The CoBRIM Trial - Impacts To My Bull Thesis 9:57 a.m. Sept. 29, 2014 - Seeking Alpha
Exelixis up on clinical trial results 7:38 a.m. Sept. 29, 2014 - Seeking Alpha
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. 7:41 p.m. Sept. 28, 2014 - GuruFocus.com
Why Exelixis (EXEL) Stock Might be a Great Pick - Tale of the Tape 8:53 a.m. Sept. 18, 2014 - Zacks.com
Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick 8:38 a.m. Sept. 16, 2014 - Seeking Alpha
Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious 8:41 a.m. Sept. 15, 2014 - Seeking Alpha
Exelixis' (EXEL) CEO Michael Morrissey Presents at Morgan Stanley Healthcare Conference (Transcript) 6:04 p.m. Sept. 9, 2014 - Seeking Alpha

Press Releases on EXEL
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Exelixis Announces PositivePreliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib 4:20 a.m. Nov. 16, 2014 - BusinessWire - BZX
Exelixis to Present at theStifel2014Healthcare Conference on Tuesday, November 18 4:40 p.m. Nov. 11, 2014 - BusinessWire - BZX
Exelixis CompletesEnrollment of the METEOR Phase 3 Pivotal Trial of Cabozantinib in Metastatic Renal Cell Carcinoma 6:04 a.m. Nov. 6, 2014 - BusinessWire - BZX
Exelixis Announces Positive Top-Line Results From a Phase 2 Trial of Cabozantinib and Erlotinib in Patients With EGFR Wild-Type Non-Small Cell Lung Cancer 4:14 p.m. Nov. 4, 2014 - BusinessWire - BZX
Exelixis Announces Third Quarter 2014 Financial Results and Provides Corporate Update 4:13 p.m. Nov. 4, 2014 - BusinessWire - BZX
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 8:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Exelixis to Release Third Quarter 2014 Financial Results on Tuesday, November 4, 2014 3:12 p.m. Oct. 14, 2014 - BusinessWire - BZX
Exelixis Announces Positive Results from Phase 3 Pivotal Trial ofCobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma 2:00 a.m. Sept. 29, 2014 - BusinessWire - BZX
Exelixis Announces Cobimetinib Phase3coBRIM Results toBePresented at ESMO 2014 Congress 12:00 a.m. Sept. 17, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Exelixis to Present at theMorgan Stanley Global Healthcare Conference on Tuesday, September 9 3:05 p.m. Sept. 8, 2014 - BusinessWire - BZX
Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trialof Cabozantinib in Men with MetastaticCastration-ResistantProstate Cancer 5:00 p.m. Sept. 1, 2014 - BusinessWire - BZX
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Exelixis Announces Second Quarter 2014 Financial Results 3:14 p.m. July 31, 2014 - BusinessWire - BZX
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 8:20 a.m. July 31, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 7:40 a.m. July 29, 2014 - PR Newswire - PRF
SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead 7:40 a.m. July 18, 2014 - PR Newswire - PRF
Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2:05 p.m. July 17, 2014 - PR Newswire - PRF
Exelixis to Release Second Quarter 2014 Financial Results on Thursday, July 31, 2014 3:06 p.m. July 16, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Podcast Giants Converge in Tennessee for POD U Summit

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Rising Food Safety Stars Honored: A Global Effort

Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...

First Citizens Surprises with Q3 Gains and Buyback Plan

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Ares Commercial Real Estate Gears Up for Q3 Earnings

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

Medicare Limits and Long-Term Care Planning Tips

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Zoomlion's Tower Cranes: Engineering Feats at Great Heights

Pushing Boundaries with Towering Achievements When you're looking up at an engineering marvel, there's a good chance mighty cranes had their heyday lifting those towering ambitions. Zoomlion Heavy Industry Science & Technology Co., Ltd. just pulled a power move at the Lugu Lake Grand Bridge's 283-meter Shangri-La-side main tower. Picture that: two R4300-200 bad boys...

QFIN Investors Eye Class Action Amid Regulatory Struggles

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Miraculous Medical Team Effort Saves Newborn's Life

A Medical Feat: Teamwork at Its Pinnacle You want a story that restores your faith in humanity? Well, this one from Memorial Healthcare System and Joe DiMaggio Children's Hospital might just do the trick. The tale of baby Jay'ce, born with a neck mass threatening his breath, is straight out of a medical drama—albeit without the Hollywood scriptwriters' spin. It’s rare...

LifeSecure Expands with Starscape Agency Launch

LifeSecure's Strategic Move into the Insurance Space LifeSecure Holdings Corporation is planting new roots with its latest venture, Starscape Insurance Agency. This ain't just another splash in the kiddie pool, buddy. This is a big step in bolstering its standing in the insurance sector, focusing sharply on health insurance solutions for individuals, families, and even...

Medline's MedTrans Rodeo: Honoring Driver Excellence

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...